Bei Patienten mit bekannten oder vermuteten kardiovaskulären Erkrankungen kann präoperativ
eine differenzierte kardiologische Abklärung erforderlich sein. Diese sollte in ausreichendem
Abstand zum operativen Eingriff erfolgen, wobei pharmakologische und interventionelle
Aspekte, ebenso wie ggf. durchzuführende Prüfungen bzw. Umprogrammierungen therapeutischer
Implantate (Herzschrittmacher/Implantierbare Cardioverter Defibrillatoren – ICD) berücksichtigt
und ggf. koordiniert werden sollten. Die Entscheidung für oder gegen eine erweiterte
präoperative Diagnostik basiert auf 4 Faktoren: dem Vorliegen einer akut symptomatischen
Herzerkrankung, dem Vorliegen kardialer Risikofaktoren beim Patienten, der Belastbarkeit
des Patienten und dem kardialen Risiko des operativen Eingriffs. Durch transparente
und verbindliche interdisziplinäre Absprachen soll damit bei kardialen Risikopatienten
eine hohe Patientenorientierung unter Vermeidung unnötiger Voruntersuchungen gewährleistet,
präoperative Untersuchungsabläufe verkürzt, sowie letztlich Kosten reduziert werden.
Preoperative differentiated cardiac clarification may be necessary in case of patients
suffering from known or suspected cardiovascular diseases. Such clarification should
be effected well before surgery. This preparatory investigation should include pharmacological
and interventional aspects as well as any necessary examinations or re-programming
of therapeutic implants such as pacemakers or implantable cardiovert defibrillators
(ICD) or if necessary co-ordination. Decision for or against extended preoperative
diagnosis depends on four factors: presence of an acute symptomatic cardiac disease,
presence of cardiac risk factors in the patient, the patient's capacity to cope with
stress factors and the cardiac risk of surgery. By means of transparent and definite
interdisciplinary agreement it should be possible to arrive at a mutual consent on
the situation of cardiac risk patients while avoiding unnecessary preoperative examinations.
This shortens preoperative procedures and finally also cuts down the overall cost.
Key words
Preoperative evaluation - cardiovascular diseases - risk patients - cardiac risk -
extended diagnostics
Literatur
1
Mangano DT.
Perioperative medicine: NHLBI working group deliberations and recommendations.
J Cardiothorac Vasc Anesth.
2004;
18
1-6
2
Fleisher LA, Beckman JA, Brown KA et al..
ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac
surgery.
Circulation.
2007;
116
1971-1996
3
Poldermans D, Bax JJ, Boersma E et al..
Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management
in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and
Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of
Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA).
Eur Heart J.
2009;
30
2769-2812
4
Poldermans D, Schouten O, Vidakovic R et al..
A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk
patients undergoing major vascular surgery: the DECREASE-V Pilot Study.
J Am Coll Cardiol.
2007;
49
1763-1769
5
Monaco M, Stassano P, Di TL et al..
Systematic strategy of prophylactic coronary angiography improves long-term outcome
after major vascular surgery in medium- to high-risk patients: a prospective, randomized
study.
J Am Coll Cardiol.
2009;
54
989-996
6
Choi JH, Cho DK, Song YB et al..
Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in
non-cardiac surgery.
Heart.
2010;
96
56-62
7
Halm EA, Browner WS, Tubau JF et al..
Echocardiography for assessing cardiac risk in patients having noncardiac surgery.
Study of Perioperative Ischemia Research Group.
Ann Intern Med.
1996;
125
433-441
8
Hammill BG, Curtis LH, nett-Guerrero E et al..
Impact of heart failure on patients undergoing major noncardiac surgery.
Anesthesiology.
2008;
108
559-567
9
Bhatia RS, Tu JV, Lee DS et al..
Outcome of heart failure with preserved ejection fraction in a population-based study.
N Engl J Med.
2006;
355
260-269
10
Dickstein K, Cohen-Solal A, Filippatos G et al..
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure
2008 of the European Society of Cardiology. Developed in collaboration with the Heart
Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive
Care Medicine (ESICM).
Eur Heart J.
2008;
29
2388-2442
11
Mancia G, De BG, Dominiczak A et al..
2007 Guidelines for the management of arterial hypertension: The Task Force for the
Management of Arterial Hypertension of the European Society of Hypertension (ESH)
and of the European Society of Cardiology (ESC).
Eur Heart J.
2007;
28
1462-1536
12
Mancia G, Laurent S, Agabiti-Rosei E et al..
Reappraisal of European guidelines on hypertension management: a European Society
of Hypertension Task Force document.
Blood Press.
2009;
18
308-347
13
Vahanian A, Baumgartner H, Bax J et al..
Guidelines on the management of valvular heart disease: The Task Force on the Management
of Valvular Heart Disease of the European Society of Cardiology.
Eur Heart J.
2007;
28
230-268
14
Iung B, Baron G, Butchart EG et al..
A prospective survey of patients with valvular heart disease in Europe: The Euro Heart
Survey on Valvular Heart Disease.
Eur Heart J.
2003;
24
1231-1243
15
Epstein AE, Dimarco JP, Ellenbogen KA et al..
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities:
a report of the American College of Cardiology/American Heart Association Task Force
on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline
Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed
in collaboration with the American Association for Thoracic Surgery and Society of
Thoracic Surgeons.
J Am Coll Cardiol.
2008;
51
1-62
16
Zipes DP, Camm AJ, Borggrefe M et al..
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias
and the prevention of sudden cardiac death: a report of the American College of Cardiology/American
Heart Association Task Force and the European Society of Cardiology Committee for
Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients
With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
J Am Coll Cardiol.
2006;
48
17
Fleischmann KE, Beckman JA, Buller CE et al..
2009 ACCF/AHA focused update on perioperative beta blockade.
J Am Coll Cardiol.
2009;
54
2102-2128
18
Geldner G, Kelm M, Leschke M, Mertens E, Meyer C, Mössner J, Obertacke U, Schwenk W,
Wappler F, Zwißler B.
Präoperative Evaluation erwachsener Patienten vor elektiven, nichtkardiochirurgischen
Eingriffen – Eine gemeinsame Empfehlung der Deutschen Gesellschaft für Anästhesiologie
und Intensivmedizin, der Deutschen Gesellschaft für Chirurgie und der Deutschen Gesellschaft
für Innere Medizin.
Anaesthesist.
online First
DOI: DOI: 10.1007/s00101-010-1793-8
2010;
59
1793-8
Korrenspondenz
Dr. med. Christian Meyer
Heinrich-Heine-Universität Düsseldorf Medizinische Fakultät Klinik für Kardiologie,
Pneumologie und Angiologie
Moorenstr. 5
40225 Düsseldorf
Fax: 0211-8118812
Email: Christian.Meyer@med. uni-duesseldorf.de